Lupus Research Alliance Announces Inaugural Recipients of Translational Bridge Award
The Lupus Research Alliance (LRA) is excited to announce the first-ever recipients of the Translational Bridge Award (TBA), established...
Monash University
Lupus Research Alliance Awards $9 Million to Develop Lupus Treatment Breakthroughs
NEW YORK, NY – August 24, 2022 – The Lupus Research Alliance (LRA) today announced its Global Team Science...
Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment
The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive...
Lupus Research Lifted Up in Everyday Health
May 27, 2021
Funding innovative research year-round is the most meaningful way the Lupus Research Alliance Lifts Up Lupus with...
Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus
Dr. Eric Morand Publishes Results Funded by LRA’s Distinguished Innovator Award
NEW YORK, NY. March 31, 2021. Results of critical...
LRA Researchers Star at ACR/ARP – Part 2
Last week we gave you only half the story of what scientists funded by the Lupus Research Alliance (LRA)...
Treat-to-Target is Feasible and Beneficial in Lupus
September 19, 2019
Treating patients with lupus until they reach specific health goals can reduce disease flares and prevent organ...